It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Reference cell atlases powered by single cell and spatial transcriptomics technologies are becoming available to study healthy and diseased tissue at single cell resolution. One important use of these data resources is to compare cell types from new dataset with cell types in the reference atlases to evaluate their phenotypic similarities and differences, for example, for identifying novel cell types under disease conditions. For this purpose, rigorously-validated computational algorithms are needed to perform these cell type matching tasks that can compare datasets from different experiment platforms and sample types. Here, we present significant enhancements to FR-Match (v2.0)—a multivariate nonparametric statistical testing approach for matching cell types in query datasets to reference atlases. FR-Match v2.0 includes a normalization procedure to facilitate cross-platform cluster-level comparisons (e.g., plate-based SMART-seq and droplet-based 10X Chromium single cell and single nucleus RNA-seq and spatial transcriptomics) and extends the pipeline to also allow cell-level matching. In the use cases evaluated, FR-Match showed robust and accurate performance for identifying common and novel cell types across tissue regions, for discovering sub-optimally clustered cell types, and for cross-platform and cross-sample cell type matching.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 J. Craig Venter Institute, La Jolla, USA (GRID:grid.469946.0)
2 J. Craig Venter Institute, La Jolla, USA (GRID:grid.469946.0); Chan Zuckerberg Initiative, Redwood City, USA (GRID:grid.507326.5) (ISNI:0000 0004 6090 4941)
3 Allen Institute for Brain Science, Seattle, USA (GRID:grid.417881.3) (ISNI:0000 0001 2298 2461)
4 J. Craig Venter Institute, La Jolla, USA (GRID:grid.469946.0); University of California San Diego, Department of Pathology, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242); La Jolla Institute for Immunology, Division of Vaccine Discovery, La Jolla, USA (GRID:grid.185006.a) (ISNI:0000 0004 0461 3162)




